Page last updated: 2024-10-29

ketamine and Metabolic Syndrome

ketamine has been researched along with Metabolic Syndrome in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.

Research Excerpts

ExcerptRelevanceReference
"Treatment with ketamine, a non-competitive glutamate N-methyl-d-aspartic acid (NMDA) receptor antagonist, is known to have paradoxical effects of neuroprotection and neurotoxicity."1.34The expression of Troponin T1 gene is induced by ketamine in adult mouse brain. ( Lowe, XR; Lu, X; Marchetti, F; Wyrobek, AJ, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lowe, XR1
Lu, X1
Marchetti, F1
Wyrobek, AJ1

Other Studies

1 other study available for ketamine and Metabolic Syndrome

ArticleYear
The expression of Troponin T1 gene is induced by ketamine in adult mouse brain.
    Brain research, 2007, Oct-12, Volume: 1174

    Topics: Age Factors; Animals; Behavior, Animal; Brain; Brain Diseases; Disease Models, Animal; Excitatory Am

2007